Grant: Project Grant
University of Toronto
$100,000.00
Modulation of cardiac cell signaling with synthetic antibodies, and their characterization as potential therapeutics and probes for basic biological research
EF 2016-17
Résumé
The critical perturbations in molecular signaling that result in functional impairment of cardiac muscle cells are poorly understood. Our motivation is to understand the changes in the molecular mechanisms of cardiomyocytes in heart failure (HF) through the application of a novel, high throughput, synthetic antibody screens using human cardiac tissue followed by extensive functional validation. Elucidation of clinically relevant signaling cascades via unbiased global monitoring is key to the evelopment of more effective markers, therapeutics, earlier detection, and perhaps even preventative treatment of HF. No such study has been attempted in the past, but a timely confluence of relevant resources now provides very high potential of identifying very innovative new research opportunities for HF research and treatment.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
366643
Name
Gramolini Anthony O
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Modulation of cardiac cell signaling with synthetic antibodies, and their characterization as potential therapeutics and probes for basic biological research
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Heart Disease; Mass Spectrometry; Phosphoproteomics; Phosphorylation Signaling
Abstract
The critical perturbations in molecular signaling that result in functional impairment of cardiac muscle cells are poorly understood. Our motivation is to understand the changes in the molecular mechanisms of cardiomyocytes in heart failure (HF) through the application of a novel, high throughput, synthetic antibody screens using human cardiac tissue followed by extensive functional validation. Elucidation of clinically relevant signaling cascades via unbiased global monitoring is key to the evelopment of more effective markers, therapeutics, earlier detection, and perhaps even preventative treatment of HF. No such study has been attempted in the past, but a timely confluence of relevant resources now provides very high potential of identifying very innovative new research opportunities for HF research and treatment.
Competitiondate
201611
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gramolini, Anthony O; Billia, Filio
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~